Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER, B.C., July 29, 2025 /CNW/ -- Equity Insider News Commentary – The average age of cancer patients is getting younger, as experts are urgently examining the rise of early-onset incidence across several different cancer types. According to the Cancer Discovery study from the National Cancer Institute (NCI), the largest increases were seen in female breast, colorectal, kidney, uterine, and pancreatic cancers. Biotechs in the oncology space are responding with optimistic new treatments with potential milestones in the near future that may shift the tide in the sector, including Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC.TO), Celcuity Inc. (NASDAQ:CELC), Evaxion A/S (NASDAQ:EVAX), Lyell Immunopharma, Inc. (NASDAQ:LYEL), and Agenus Inc. (NASDAQ:AGEN).
Read more at newswire.ca
/A%20concept%20image%20of%20space_%20Image%20by%20Canities%20via%20Shutterstock_.jpg)
/A%20concept%20image%20of%20a%20flying%20car_%20Image%20by%20Phonlamai%20Photo%20via%20Shutterstock_.jpg)
